Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Cancer Type/Condition:
Breast cancer, female
Trial Type:
All
Treatment/Intervention:
high-dose chemotherapy
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 3 cm
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 20
Sponsor:
Other
Protocol IDs:
200803006M
, NCT00776724
2.
Safety of Human Lactoferrin hLF1-11 for the Treatment of Infectious Complications Among Haematopoietic Stem Cell Transplant Recipients
Phase:
Phase II, Phase I
Type:
Supportive care
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AMP 02-02; SC13
, EudraCT No. 2006-004012-52, NCT00430469
3.
Phase II Pilot Study of High-Dose Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation and Immunotherapy With Activated T Cells in Women With Stage IV Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
WSU-2007-033
, NCT00020722, RWMC-0634246
4.
Phase II Study of Tandem High-Dose Chemotherapy Comprising Melphalan, Carboplatin, Thiotepa, and Cyclophosphamide With or Without Trastuzumab (Herceptin®) Followed By Autologous Peripheral Blood Stem Cell Transplantation and Helical Tomotherapy or Loco-Regional Radiotherapy in Patients With High-Risk Stage IIIB, IIIC, or IV Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
65 and under
Sponsor:
NCI
Protocol IDs:
CHNMC-05042
, IRB 05042, NCT00182793
5.
Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 60
Sponsor:
Other
Protocol IDs:
2006-0280
, NCT00429182
6.
High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
UWCC-6954
, NCI-2009-01309, NCT00992602
7.
Immuno 1: Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Stem Cell Transplant
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
Not specified
Sponsor:
Other
Protocol IDs:
133/04
, NCT00231712
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
